TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17922883

Group type: EXPERIMENTAL
Intervention: MDI + SP (metered dose inhaler plus spacer)
Number of subjects: 30

Group type: COMPARATOR
Intervention: NEB (Sidestream nebulizer)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: MDI + SP
Number of subjects: 30
Study: 15919182

Group type: EXPERIMENTAL
Intervention: N400 amplitude to non-exemplars
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: N400 amplitude to high-typicality exemplars
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: N400 amplitude to low-typicality exemplars
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: N400 amplitude difference between non-exemplars and both low- and high-typicality exemplars
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: N400 amplitude difference between low- and high-typicality exemplars
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: N400 amplitude differences between non-exemplars and both types of exemplars
Number of subjects: 0
Study: 12815491

Group type: EXPERIMENTAL
Intervention: Community volunteers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Village government personnel
Number of subjects: 0
Study: 10448447

Group type: EXPERIMENTAL
Intervention: Volunteer befriending
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fresh-start experiences
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard attachment style
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New severe stressors and poor coping strategies
Number of subjects: 0
Study: 7540445

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch 200,000/0.62 6%
Number of subjects: 24

Group type: COMPARATOR
Intervention: Human albumin 5%
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Isovolemic hemodilution
Number of subjects: 24
Study: 2085986

Group type: EXPERIMENTAL
Intervention: Fosfomycin trometamol (3 g)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Norfloxacin (800 mg)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 89
Study: 398184

Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pindolol
Number of subjects: 0
Study: 31232920

Group type: EXPERIMENTAL
Intervention: CCR with PBM Therapy (CR-PBM)
Number of subjects: 90

Group type: COMPARATOR
Intervention: CCR and placebo PBM Therapy (CR-PlaceboPBM)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control, only cardiorespiratory rehabilitation (CCR)
Number of subjects: 90
Study: 28715325

Group type: EXPERIMENTAL
Intervention: Inference-based framework for privacy-preserving similarity search in Hamming space; specific dosage and duration not applicable.
Number of subjects: 0
Study: 26968623

Group type: EXPERIMENTAL
Intervention: Mometasone furoate (investigational drug)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control drug (mometasone furoate)
Number of subjects: 0
Study: 25050491

Group type: EXPERIMENTAL
Intervention: Cyclosporine (2.5 mg/kg)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 61
Study: 22245487

Group type: EXPERIMENTAL
Intervention: Salmeterol
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 18996662

Group type: EXPERIMENTAL
Intervention: TEVAR (thoracic endovascular aortic repair)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 88
Study: 18269128

Group type: EXPERIMENTAL
Intervention: Sandblasting (sand) with Al2O3 50 microm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chloroform (CHCl3) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chloroform (CHCl3) + Silane (sil) treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sandblasting (sand) + Silane (sil) treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Silane (sil) treatment
Number of subjects: 0
Study: 15649877

Group type: COMPARATOR
Intervention: Side motion tests
Number of subjects: 9

Group type: COMPARATOR
Intervention: Head-up tilt tests
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Spontaneous arousals
Number of subjects: 9

Group type: COMPARATOR
Intervention: HR variability during slow-wave sleep (SWS)
Number of subjects: 9
Study: 12191661

Group type: COMPARATOR
Intervention: All Bond 2 with C & B (Bisco)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Scotchbond Multipurpose Plus with Opal Luting Composite (3M)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Scotchbond 1 in combination with Rely X ARC resin cement (3M)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: One‐step with C & B resin cement (Bisco)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: All Bond Experimental with Post Cement HI‐X (Bisco)
Number of subjects: 50
Study: 9809626

Group type: EXPERIMENTAL
Intervention: IFN-alpha2b (3 x 10(6)U)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 24
Study: 7715295

Group type: EXPERIMENTAL
Intervention: Grapefruit juice
Number of subjects: 14

Group type: COMPARATOR
Intervention: Orange juice
Number of subjects: 14

Group type: COMPARATOR
Intervention: Water
Number of subjects: 14
Study: 2720328

Group type: EXPERIMENTAL
Intervention: Above-knee graduated compression stockings
Number of subjects: 114

Group type: COMPARATOR
Intervention: Below-knee graduated compression stockings
Number of subjects: 114
Study: 1087955

Group type: EXPERIMENTAL
Intervention: Pentamidine isethionate
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Pyrimethamine-sulfadiazine
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Combination of both regimens
Number of subjects: 21
Study: 7426275

Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Beta‐methyl digoxin (medigoxin)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Ouabain
Number of subjects: 4
Study: 31623611

Group type: EXPERIMENTAL
Intervention: Processed red meat with high drinking water nitrate (3.7 mg/kg bodyweight)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Unprocessed white meat with high drinking water nitrate (3.7 mg/kg bodyweight)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Processed red meat
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Unprocessed white meat
Number of subjects: 20
Study: 28705539

Group type: EXPERIMENTAL
Intervention: Immediate instillation of mitomycin C (MMC) within 24 hours after TURBT
Number of subjects: 2243

Group type: COMPARATOR
Intervention: Delayed instillation of mitomycin C (MMC) 2 weeks after TURBT
Number of subjects: 2243

Group type: EXPERIMENTAL
Intervention: Immediate instillation of mitomycin C (MMC)
Number of subjects: 2243

Group type: COMPARATOR
Intervention: Delayed instillation of mitomycin C (MMC)
Number of subjects: 2243
Study: 27654259

Group type: EXPERIMENTAL
Intervention: Metformin (conventional antidiabetic doses)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (30 healthy donors)
Number of subjects: 60
Study: 24463451

Group type: EXPERIMENTAL
Intervention: teriparatide (20 μg recombinant human parathyroid hormone)
Number of subjects: 79

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: teriparatide
Number of subjects: 79
Study: 22340202

Group type: EXPERIMENTAL
Intervention: Chest ultrasound (US)
Number of subjects: 98
Study: 20719253

Group type: EXPERIMENTAL
Intervention: Budesonide 800 μg twice daily for 12 months
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study: 17926437

Group type: EXPERIMENTAL
Intervention: High-efficacy condition
Number of subjects: 28

Group type: COMPARATOR
Intervention: Low-efficacy condition
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Moderate intensity cycling session
Number of subjects: 28
Study: 16170180

Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy (CRT); concurrent cisplatin (25 mg/m2 on days 1 to 4) on weeks 1, 4, and 7 of RT and adjuvant cisplatin (20 mg/m2 on days 1 to 4) and fluorouracil (1,000 mg/m2 on days 1 to 4) every 4 weeks for three cycles after completion of RT
Number of subjects: 221

Group type: COMPARATOR
Intervention: Radiotherapy (RT) alone; 70 Gy in 7 weeks
Number of subjects: 221
Study: 11948051

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IP)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study: 9568915

Group type: EXPERIMENTAL
Intervention: Clinical information collected from parents regarding the progression of Canavan disease.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Clinical information collected from parents regarding the clinical course of Canavan disease.
Number of subjects: 60
Study: 7613554

Group type: EXPERIMENTAL
Intervention: Moguisteine (100 mg t.i.d.)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Codeine 15 mg (t.i.d.)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Codeine 30 mg (t.i.d.)
Number of subjects: 119
Study: 2387517

Group type: EXPERIMENTAL
Intervention: Experimental stents without side holes
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional stents
Number of subjects: 40
Study: 576296

Group type: EXPERIMENTAL
Intervention: Constant intravenous infusion of regular insulin (2 units/hour)
Number of subjects: 8

Group type: COMPARATOR
Intervention: NPH insulin (two thirds of daily maintenance doses)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Preoperative NPH insulin and 1 unit/hour insulin administration
Number of subjects: 8
Study: 31804876

Group type: EXPERIMENTAL
Intervention: Rituximab maintenance after R-CHOP
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Rituximab maintenance after R-FC
Number of subjects: 560

Group type: COMPARATOR
Intervention: R-CHOP
Number of subjects: 560

Group type: COMPARATOR
Intervention: R-FC
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Rituximab maintenance
Number of subjects: 560
Study: 29209926

Group type: EXPERIMENTAL
Intervention: Prophylactic phenylephrine infusion (50 μg·min‐1, titrated)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Phenylephrine bolus dosing (100 μg)
Number of subjects: 160
Study: 26742011

Group type: EXPERIMENTAL
Intervention: GP-endorsed invitation letter
Number of subjects: 265434

Group type: COMPARATOR
Intervention: Standard invitation letter
Number of subjects: 265434

Group type: EXPERIMENTAL
Intervention: Implementation of GPE
Number of subjects: 265434

Group type: EXPERIMENTAL
Intervention: Modification of standard invitation
Number of subjects: 265434
Study: 24048950

Group type: EXPERIMENTAL
Intervention: Test formulation of irbesartan 300 mg film-coated tablet
Number of subjects: 40
Study: 23649068

Group type: EXPERIMENTAL
Intervention: Acid + single bond + sealant (Group 2)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Protect bond + sealant (Group 6)
Number of subjects: 60

Group type: COMPARATOR
Intervention: S (3) bond + sealant (Group 4)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Acid + saliva + single bond + sealant (Group 1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Saliva + S (3) bond + sealant (Group 3)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Saliva + protect bond + sealant (Group 5)
Number of subjects: 60
Study: 20845670

Group type: EXPERIMENTAL
Intervention: General inhalational anesthesia with sevoflurane (group S)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia with propofol (group T)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Regional anesthesia (group R)
Number of subjects: 45
Study: 18219299

Group type: EXPERIMENTAL
Intervention: Low-sodium diet (LS; 50 mmol Na(+)/24 h)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: High-sodium diet (HS; 200 mmol Na(+)/24 h)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: High-sodium diet with ACE inhibitor (HS-ACEi; enalapril 20 mg/day)
Number of subjects: 34
Study: 16014874

Group type: EXPERIMENTAL
Intervention: Intensive discharge planning services and community-based case management services
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Less-intensive discharge planning and no community-based services
Number of subjects: 1400
Study: 12664021

Group type: EXPERIMENTAL
Intervention: Fluocinolone acetonide 0.01% in peanut oil
Number of subjects: 81

Group type: COMPARATOR
Intervention: Vehicle oil alone
Number of subjects: 81
Study: 10758845

Group type: EXPERIMENTAL
Intervention: Verum acupuncture (n = 28)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo acupuncture
Number of subjects: 56
Study: 8694217

Group type: EXPERIMENTAL
Intervention: 2% lignocaine 2 ml with 1:200,000 adrenaline
Number of subjects: 36

Group type: COMPARATOR
Intervention: Normal saline 2 ml
Number of subjects: 36
Study: 1398272

Group type: EXPERIMENTAL
Intervention: Intracervical prostaglandin E2 gel (0.5 mg)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Intravenous oxytocin
Number of subjects: 165
Study: 4025314

Group type: EXPERIMENTAL
Intervention: Bovine heparin #1
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Bovine heparin #2
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Porcine gut heparin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 40
Study: 29754671

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg twice daily
Number of subjects: 6500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6500
Study: 27037227

Group type: EXPERIMENTAL
Intervention: Aerobic Exercise Training (AET)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 31
Study: 25134225

Group type: EXPERIMENTAL
Intervention: Infants' health care charges
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Infants' morbidity
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Well-baby clinic visit
Number of subjects: 139
Study: 21194762

Group type: EXPERIMENTAL
Intervention: High dose tirofiban
Number of subjects: 1398

Group type: COMPARATOR
Intervention: Bleeding
Number of subjects: 1398
Study: 20370419

Group type: EXPERIMENTAL
Intervention: SRP+SDD
Number of subjects: 41

Group type: COMPARATOR
Intervention: SRP+placebo
Number of subjects: 41
Study: 18236729

Group type: EXPERIMENTAL
Intervention: Conservative strategy (fluid restriction)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Liberal strategy (fluid intake)
Number of subjects: 1000
Study: 15892438

Group type: EXPERIMENTAL
Intervention: Generic health-related instruments administered first (SF-36 followed by HADS)
Number of subjects: 1015

Group type: EXPERIMENTAL
Intervention: Vision-targeted instruments administered first (NEI-VFQ followed by SST-VPVS)
Number of subjects: 1015
Study: 12684289

Group type: EXPERIMENTAL
Intervention: BPV plus conventional therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional therapy alone (Control)
Number of subjects: 30
Study: 10098826

Group type: EXPERIMENTAL
Intervention: Treatment of generalized anxiety, panic, and dysthymic disorders
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Hypochondriacal personality disorder
Number of subjects: 181

Group type: COMPARATOR
Intervention: Other personality disorders
Number of subjects: 181
Study: 9345409

Group type: EXPERIMENTAL
Intervention: Copolymer I (20 mg daily subcutaneous injection)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 251
Study: 2050174

Group type: EXPERIMENTAL
Intervention: Sublingual captopril (25 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Peroral captopril (25 mg)
Number of subjects: 8
Study: 6410442

Group type: EXPERIMENTAL
Intervention: flurazepam (30 mg)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: tryptophan (1 g)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: secobarbital (100 mg)
Number of subjects: 96

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 96
Study: 31010449

Group type: EXPERIMENTAL
Intervention: Integrated, exposure-based treatment (COPE)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Non-exposure-based, SUD-only treatment (RP)
Number of subjects: 71
Study: 30947686

Group type: EXPERIMENTAL
Intervention: Intensive care group
Number of subjects: 106

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Intensive care participants
Number of subjects: 106
Study: 30428858

Group type: EXPERIMENTAL
Intervention: Dietary intake meeting Children's Food Trust (CFT) guidelines
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Physical activity (PA)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Minutes spent in light PA
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Active time
Number of subjects: 150
Study: 27028980

Group type: EXPERIMENTAL
Intervention: Metoclopramide (10 mg/d, up-titrated to 30 mg/d)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Metoclopramide
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 24690571

Group type: EXPERIMENTAL
Intervention: Cerebral perfusion pressure-targeted therapy (n = 55)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Intracranial pressure-targeted therapy (n = 55)
Number of subjects: 110
Study: 22240353

Group type: EXPERIMENTAL
Intervention: 10 mg RES capsule daily for 3 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 20375811

Group type: EXPERIMENTAL
Intervention: Robotically assisted laparoscopic radical hysterectomy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Open radical hysterectomy
Number of subjects: 60
Study: 17549295

Group type: EXPERIMENTAL
Intervention: Low-dose HT (1 mg 17ss-oestradiol + 0.5 mg norethisterone acetate) (n = 50)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Conventional-dose HT (2 mg 17ss-oestradiol and 1 mg NETA) (n = 50)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Tibolone (2.5 mg) (n = 51)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg) (n = 51)
Number of subjects: 202
Study: 15333616

Group type: EXPERIMENTAL
Intervention: Incremental exercise test to exhaustion on a treadmill
Number of subjects: 300

Group type: COMPARATOR
Intervention: Men
Number of subjects: 300
Study: 12123487

Group type: EXPERIMENTAL
Intervention: gemfibrozil (600 mg twice daily)
Number of subjects: 65

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 65
Study: 9863873

Group type: EXPERIMENTAL
Intervention: Monotherapy arms (zidovudine, zalcitabine, didanosine)
Number of subjects: 722

Group type: EXPERIMENTAL
Intervention: Combination therapies (zidovudine, zalcitabine, didanosine)
Number of subjects: 722

Group type: EXPERIMENTAL
Intervention: Overall adherence assessment
Number of subjects: 722

Group type: EXPERIMENTAL
Intervention: Overall non-adherence behaviors
Number of subjects: 722
Study: 8568176

Group type: EXPERIMENTAL
Intervention: Hysterosonography with sterile saline injection using a novel catheter
Number of subjects: 220
Study: 1636617

Group type: EXPERIMENTAL
Intervention: Monounsaturated fatty acids (MUFAs)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Carbohydrate (CHO) diet
Number of subjects: 17
Study: 6201083

Group type: EXPERIMENTAL
Intervention: Dextran infusion with hapten blockade (monovalent dextran-1)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Dextran infusion
Number of subjects: 116
Study: 31996363

Group type: EXPERIMENTAL
Intervention: NEPA
Number of subjects: 60

Group type: COMPARATOR
Intervention: APR
Number of subjects: 60
Study: 31479306

Group type: EXPERIMENTAL
Intervention: Anastrozole (1 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exemestane (25 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose tamoxifen
Number of subjects: 0
Study: 29849453

Group type: EXPERIMENTAL
Intervention: Smart nebulization
Number of subjects: 65

Group type: COMPARATOR
Intervention: Conventional nebulization
Number of subjects: 65
Study: 26946734

Group type: EXPERIMENTAL
Intervention: Twirling reinforcing manipulation
Number of subjects: 126

Group type: COMPARATOR
Intervention: Mild reinforcing-reducing manipulation
Number of subjects: 126

Group type: COMPARATOR
Intervention: Twirling reducing manipulation
Number of subjects: 126
Study: 24597764

Group type: EXPERIMENTAL
Intervention: Xenogeneic collagen matrix (CM)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Free gingival graft (FGG)
Number of subjects: 30
Study: 22015574

Group type: EXPERIMENTAL
Intervention: Action Planning (AP) program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Action Planning plus (AP+) program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 19897461

Group type: EXPERIMENTAL
Intervention: External counterpulsation (ECP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham ECP
Number of subjects: 20
Study: 18058723

Group type: EXPERIMENTAL
Intervention: Low carbohydrate diet (45% of energy from carbohydrates)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High carbohydrate diet (65% of energy from carbohydrates)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 30
Study: 16284385

Group type: EXPERIMENTAL
Intervention: Broccoli sprouts infusion containing 400 micromol glucoraphanin
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Broccoli sprouts infusion containing < 3 micromol glucoraphanin
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 200
Study: 12383039

Group type: EXPERIMENTAL
Intervention: Fondaparinux sodium 2.5mg subcutaneously
Number of subjects: 8
Study: 9159442

Group type: EXPERIMENTAL
Intervention: Follicular induction and exposure to laboratory conditions
Number of subjects: 4

Group type: COMPARATOR
Intervention: Embryos obtained before 1991
Number of subjects: 4
Study: 8131453

Group type: EXPERIMENTAL
Intervention: Aerobic training at ventilatory threshold (Vth) intensity level for three months, three times per week.
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no training).
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 20-MST (20-meter shuttle test) as an indirect measure.
Number of subjects: 48
Study: 3113823

Group type: EXPERIMENTAL
Intervention: LNG‐IUD (n = 14 women)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Norplant (R)‐2 (n = 14 women)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: LNG minipills (n = 10 women)
Number of subjects: 38
Study: 31464548

Group type: EXPERIMENTAL
Intervention: Single SUI treatment (Group 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two SUI treatments (Group 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CMRF Viveve System
Number of subjects: 0